HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Are in-vitro platelet function tests useful in predicting blood loss following open heart surgery?

AbstractBACKGROUND:
We investigated the suitability of two commercially available in-vitro bleeding tests (IVBT), the PFA-100 and the Hepcon HMS, to predict blood loss following operations with extracorporeal circulation (ECC) and compared them with conventional coagulation studies.
METHODS:
In 40 patients subjected to elective open heart surgery with ECC a blood sample was taken before and after ECC to measure platelet count, prothrombin time, aPTT, D-dimers, fibrinogen, and PFA-100 and Hepcon HMS data. The postoperative blood loss was recorded hourly until removal of drains.
RESULTS:
A significant correlation was found between total blood loss (250-1750 ml) and the preoperative PFA-100 (r = 0.41, p = 0.022), the preoperative platelet count (r = -0.42, p = 0.007), the preoperative D-dimer concentration in the plasma (r = 0.41, p = 0.01), and duration of ECC (r = 0.35, p = 0.044). There was no significant correlation between blood loss and the Hepcon HMS system.
CONCLUSIONS:
Although a significant correlation was found between blood loss and the PFA-100 IVBT, the practical value of these tests in the clinical situation is limited due to a great variability in individual results.
AuthorsA Wahba, S Sander, D E Birnbaum
JournalThe Thoracic and cardiovascular surgeon (Thorac Cardiovasc Surg) Vol. 46 Issue 4 Pg. 228-31 (Aug 1998) ISSN: 0171-6425 [Print] Germany
PMID9776498 (Publication Type: Journal Article)
Topics
  • Aged
  • Blood Loss, Surgical
  • Cardiac Surgical Procedures
  • Elective Surgical Procedures
  • Extracorporeal Circulation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pilot Projects
  • Platelet Function Tests
  • Predictive Value of Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: